SARA HAMMERSTAD ENDOKRINOLOG AS

1177 OSLO

Finances

Return on Equity

145,59 %

Current Ratio

2,36

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 062 000	3 757 000	3 494 000	1 059 000
Net Income	4 493 000	1 037 000	740 000	522 000
Total Assets	5 016 000	2 880 000	3 893 000	3 608 000
Total Equity	3 086 000	1 129 000	1 293 000	552 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 062 000	3 757 000	3 494 000	1 059 000
Expenditure	2 044 000	2 418 000	2 517 000	877 000
Operating Profit	1 018 000	1 339 000	977 000	182 000
Financial Income	3 725 000	0	0	400 000
Financial Costs	0	7 000	26 000	20 000
Financial Balance	3 725 000	−7 000	−26 000	380 000
Earnings Before Tax	4 743 000	1 332 000	952 000	561 000
Tax	250 000	295 000	212 000	39 000
Net Income	4 493 000	1 037 000	740 000	522 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	467 000	2 717 000	2 967 000	3 217 000
Total Current Assets	4 549 000	163 000	926 000	392 000
Total Assets	5 016 000	2 880 000	3 893 000	3 608 000
Total Retained Equity	3 056 000	1 099 000	1 263 000	522 000
Total Equity	3 086 000	1 129 000	1 293 000	552 000
Total Long-Term Debt	0	1 106 000	2 145 000	2 945 000
Total Current Debt	1 930 000	645 000	455 000	111 000
Total Equity and Debt	5 016 000	2 880 000	3 893 000	3 608 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	3 027 000	3 742 000	3 482 000	1 051 000
Other Income	36 000	15 000	12 000	8 000
Revenue	3 062 000	3 757 000	3 494 000	1 059 000
Cost of Goods Sold	9 000	8 000	−13 000	−17 000
Salary Costs	467 000	939 000	928 000	339 000
Depreciation	250 000	250 000	250 000	83 000
Impairment	0	0	0	0
Expenditure	2 044 000	2 418 000	2 517 000	877 000
Operating Profit	1 018 000	1 339 000	977 000	182 000
Financial Income	3 725 000	0	0	400 000
Financial Costs	0	7 000	26 000	20 000
Financial Balance	3 725 000	−7 000	−26 000	380 000
Dividends	2 537 000	1 200 000	0	0
Net Income	4 493 000	1 037 000	740 000	522 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	417 000	667 000	917 000	1 167 000
Total Intangible Assets	417 000	667 000	917 000	1 167 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	50 000	2 050 000	2 050 000	2 050 000
Total Fixed Assets	467 000	2 717 000	2 967 000	3 217 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	4 440 000	137 000	889 000	381 000
Total Current Assets	4 549 000	163 000	926 000	392 000
Total Assets	5 016 000	2 880 000	3 893 000	3 608 000
Total Equity	3 086 000	1 129 000	1 293 000	552 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	1 106 000	2 145 000	2 945 000
Creditors	5 000	59 000	2 000	−8 000
Unpaid Taxes	7 000	70 000	67 000	55 000
Dividends	2 537 000	1 200 000	0	0
Other Current Debt	163 000	201 000	164 000	61 000
Total Current Debt	1 930 000	645 000	455 000	111 000
Total Equity and Debt	5 016 000	2 880 000	3 893 000	3 608 000

Financial indicators	2022	2021	2020	2019
Return on Equity	145,59 %	91,85 %	57,23 %	94,57 %
Debt-to-Equity Ratio	0	0,98	1,66	5,34
Operating Profit Margin	33,25 %	35,64 %	27,96 %	17,19 %
Current Ratio	2,36	0,25	2,04	3,53
Quick Ratio	2,36	0,25	2,04	3,53
Equity Ratio	0,62	0,39	0,33	0,15
Gross Profit Margin	99,71 %	99,79 %	100,37 %	101,61 %